717 related articles for article (PubMed ID: 26379281)
21. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
[TBL] [Abstract][Full Text] [Related]
22. Central nervous system immune reconstitution inflammatory syndrome in AIDS: experience of a Mexican neurological centre.
Guevara-Silva EA; Ramírez-Crescencio MA; Soto-Hernández JL; Cárdenas G
Clin Neurol Neurosurg; 2012 Sep; 114(7):852-61. PubMed ID: 22326129
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for Kaposi's sarcoma in human immunodeficiency virus patients after initiation of antiretroviral therapy: A nested case-control study in Kenya.
Lupia R; Wabuyia PB; Otiato P; Fang CT; Tsai FJ
J Microbiol Immunol Infect; 2017 Dec; 50(6):781-788. PubMed ID: 26712092
[TBL] [Abstract][Full Text] [Related]
24. Factors associated with therapeutic success in HIV-positive individuals in southern Brazil.
Silveira MP; Maurer P; Guttier MC; Moreira LB
J Clin Pharm Ther; 2015 Apr; 40(2):192-5. PubMed ID: 25422132
[TBL] [Abstract][Full Text] [Related]
25. Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy.
Mönkemüller KE; Call SA; Lazenby AJ; Wilcox CM
Am J Gastroenterol; 2000 Feb; 95(2):457-62. PubMed ID: 10685750
[TBL] [Abstract][Full Text] [Related]
26. The importance of bacterial sepsis in intensive care unit patients with acquired immunodeficiency syndrome: implications for future care in the age of increasing antiretroviral resistance.
Rosenberg AL; Seneff MG; Atiyeh L; Wagner R; Bojanowski L; Zimmerman JE
Crit Care Med; 2001 Mar; 29(3):548-56. PubMed ID: 11373418
[TBL] [Abstract][Full Text] [Related]
27. A rare case of an HIV-seronegative AIDS patient with Pneumocystis jirovecii pneumonia.
Yan S; Huang J; Zheng Q; Zhu H; Gao Z; Feng J; Xu Y
BMC Infect Dis; 2019 Jun; 19(1):525. PubMed ID: 31200652
[TBL] [Abstract][Full Text] [Related]
28. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
[TBL] [Abstract][Full Text] [Related]
29. [Pneumocystis Pneumonia in 107 HIV Infected Patients Admitted to the Department of Infectious Diseases at Santa Maria Hospital, Lisbon (2002 - 2013)].
Grilo V; Pereira A
Acta Med Port; 2016 Oct; 29(10):639-650. PubMed ID: 28103460
[TBL] [Abstract][Full Text] [Related]
30. Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy.
Smith CJ; Sabin CA; Youle MS; Kinloch-de Loes S; Lampe FC; Madge S; Cropley I; Johnson MA; Phillips AN
J Infect Dis; 2004 Nov; 190(10):1860-8. PubMed ID: 15499544
[TBL] [Abstract][Full Text] [Related]
31. Sub-optimal CD4 recovery on long-term suppressive highly active antiretroviral therapy is associated with favourable outcome.
Onen NF; Overton ET; Presti R; Blair C; Powderly WG; Mondy K
HIV Med; 2009 Aug; 10(7):439-46. PubMed ID: 19459993
[TBL] [Abstract][Full Text] [Related]
32. Patients presenting with AIDS in the HAART era: a collaborative cohort analysis.
Mussini C; Manzardo C; Johnson M; Monforte Ad; Uberti-Foppa C; Antinori A; Gill MJ; Sighinolfi L; Borghi V; Lazzarin A; Miró JM; Sabin C;
AIDS; 2008 Nov; 22(18):2461-9. PubMed ID: 19005269
[TBL] [Abstract][Full Text] [Related]
33. Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy.
Hung CC; Chen MY; Hsiao CF; Hsieh SM; Sheng WH; Chang SC
AIDS; 2003 Dec; 17(18):2615-22. PubMed ID: 14685055
[TBL] [Abstract][Full Text] [Related]
34. Improvement of HAART in Brazil, 1998-2008: a nationwide assessment of survival times after AIDS diagnosis among men who have sex with men.
Malta M; da Silva CM; Magnanini MM; Wirtz AL; Perissé AR; Beyrer C; Strathdee SA; Bastos FI
BMC Public Health; 2015 Mar; 15():226. PubMed ID: 25886530
[TBL] [Abstract][Full Text] [Related]
35. [Efficacy of the treatment and secondary antifungal prophylaxis in AIDS-related histoplasmosis. Experience at the Francisco J. Muñiz Infectious Diseases Hospital in Buenos Aires].
Negroni R; Messina F; Arechavala A; Santiso G; Bianchi M
Rev Iberoam Micol; 2017; 34(2):94-98. PubMed ID: 28391953
[TBL] [Abstract][Full Text] [Related]
36. Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study.
Omland LH; Weis N; Skinhøj P; Laursen A; Christensen PB; Nielsen HI; Møller A; Engsig F; Sørensen HT; Obel N
HIV Med; 2008 May; 9(5):300-6. PubMed ID: 18400077
[TBL] [Abstract][Full Text] [Related]
37. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
[TBL] [Abstract][Full Text] [Related]
38. Dynamics of T-cell subsets and their relationship with oral and systemic opportunistic infections in HIV/AIDS patients during the first year of HAART in Guangxi, China.
Zhang L; Huang Y; Liu Z; Liu W; Qin Q; Tao R
J Med Virol; 2015 Jul; 87(7):1158-67. PubMed ID: 25777553
[TBL] [Abstract][Full Text] [Related]
39. [Pneumocystis jiroveci pneumonia characteristics in adults with AIDS with or without antiretroviral therapy].
Bahamondes M L; Villar Z MJ; Orellana C C; González R J; Montenegro U C
Rev Chilena Infectol; 2006 Sep; 23(3):215-9. PubMed ID: 16896493
[TBL] [Abstract][Full Text] [Related]
40. AIDS-related opportunistic illnesses and early initiation of HIV care remain critical in the contemporary HAART era: a retrospective cohort study in Taiwan.
Lee CY; Tseng YT; Lin WR; Chen YH; Tsai JJ; Wang WH; Lu PL; Tsai HC
BMC Infect Dis; 2018 Jul; 18(1):352. PubMed ID: 30055564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
